CI-943 is primarily investigated for its potential therapeutic applications in the field of medicine. It has shown promise as an antipsychotic agent, particularly in the treatment of schizophrenia and other psychiatric disorders. The compound is studied for its ability to modulate neurotransmitter activity in the brain, which may help alleviate symptoms such as hallucinations, delusions, and cognitive impairments. Additionally, CI-943 is being explored for its potential use in managing mood disorders and anxiety, owing to its effects on the central nervous system. Research continues to evaluate its efficacy, safety profile, and long-term benefits in clinical settings.